Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric eltrombopag trial in previously treated chronic ITP
2006-002946-13Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in immune thrombocytopenia (ITP) comparing Eltrombopag with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2009; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2006-002946-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002946-13.